Introduction
Members of the ras gene family encode small guanine nucleotide-binding proteins localized to the inner surface of the plasma membrane that play central roles in the signal transduction pathways in mammalian cells (1) (2) (3) . Activated GTP-Ras associates with the c-Raf protein kinase and contributes to its activation; Raf has been shown to phosphorylate and activate MAPKK (mitogen-activated protein kinase kinase), also known as MEK, which in turn phosphorylates and activates mitogen-activated protein kinases (also described as extracellular signal-regulated kinases (4) (5) (6) (7) (8) (9) . The extracellular signal-related kinases translocate to the nucleus and preferentially stimulate the activity of nuclear transcription factors (e.g., the activator protein-1 [AP- 1] protein c-Jun) (10) (11) (12) (13) (14) (15) . This cellular cascade culminates eventually in the malignant transformation or differentiation of a number of eukaryotic cell types (11, 12) . The transforming property of v-Ha-ras and the ability of this gene to immortalize various cell types are well established (13, 16); however, much less is known about the role of Ras in normal cellular differentiation and development.
Oncogenic Ha-ras induces neuroendocrine differentiation in rat pheochromocytoma (PC12) cells (17) (18) (19) (20) and medullary thyroid carcinoma cells (21) , and results in the differentiation of 3T3-L1 fibroblasts to adipocytes (22) . This Ras-mediated response appears to be highly tissue specific, because Thorburn et al. (23) demonstrated that activated Ras induces a differentiated phenotype in cardiac muscle cells, but inhibits differentiation in skeletal muscle. In addition, stable transfection of the Ha-ras oncogene leads to the morphologic differentiation of the human colon cancer line CaCo2 into a small bowel phenotype as characterized by a decreased proliferative capacity and an increased expression of the brush border hydrolase genes sucrase-isomaltase and alkaline phosphatase, enzymes normally produced in the terminally differentiated enterocytes of the gut (24) . These findings suggest that Ras may play a dominant role in gut differentiation and the eventual expression of various terminally differentiated products (e.g., gut hormones). Further evidence to support this hypothesis is provided by the finding of low levels of p2lr'S in the undifferentiated, rapidly proliferating crypt cells but increased expression of endogenous p2lras in the most mature cells of the gastrointestinal (GI) mucosa such as villus tip cells and endocrine cells (25) . Neurotensin (NT) , an important regulatory hormone of the gut, is localized in the GI tract to specialized enteroendocrine cells (N cells) of the adult small bowel (for review see reference 26). NT facilitates translocation of fatty acids in the proximal including secretion, motility, and gut mucosal growth (28) (29) (30) (31) (32) (33) (34) (35) (36) . Expression of the gene encoding NT and the structurally related hexapeptide neuromedin N (designated NT/N) is developmentally regulated in the gut of both rat and human in a distinctive temporal-and spatial-specific distribution (37, 38) . NT/N expression is initially low in the fetus but rapidly increases after birth to assume the distinctive adult topographical distribution of increasing NT/N expression along the longitudinal axis of the small bowel. Using isolated gut segments from the rat implanted as xenografts in athymic nude mice, we recently demonstrated that the strict temporal-and spatial-specific pattern of NT/N expression is not affected by either location or luminal contents, thus suggesting an intrinsic program of NT/N gene expression (39) . In the human colon, NT/N is transiently expressed during a developmental stage (midgestation) that is characterized by morphologic and functional similarity to the small bowel (40, 41) ; however, expression of NT/N is not apparent in the colon of the newborn or the adult (37) . Taken together, these studies identify the NT/N gene as an important endocrine model to better delineate the complex mechanisms leading to differentiation of the gut to either a small bowel or colonic phenotype.
The purpose of this study was to determine whether the Ras regulatory pathway plays a role in the expression of NT/N, a gut hormone specifically produced in terminally differentiated endocrine cells of the adult small bowel. Our findings demonstrate that either stable or transient transfection of activated Ha-ras into the CaCo2 cell line is associated with constitutive activation of NT/N gene expression, which appears to be mediated by an induction of NT/N gene transcription; a proximal AP-l/CRE promoter element of the NT/N gene is crucial for this activation. In addition, cotransfection of wild-type Ha-ras results in a modest increase in NT/N promoter activity; this induction was blocked by a plasmid encoding a dominant-negative Raf kinase. Furthermore, in the CaCo2 cell system, we are able to demonstrate concomitant increases of p21 ' (43) . Hybridization and washing conditions were described previously (44, 45) . Blots were stripped and reprobed with the constitutively expressed GAPDH gene to ensure intact RNA samples.
For RNase protection assays, poly(A)+ RNA from nontransfected CaCo2 and CaCo2-ras was hybridized with the human NT/N cRNA probe (pHNT EO.9). To ensure proper transcriptional initiation and confirm findings by functional promoter analyses, CaCo2 cells transiently transfected with rat NT/N 5' deletion vectors (with or without the ras expression vector) were harvested 48 h after transfection. Hybrid rat NT/N-CAT mRNA transcripts were detected using an RNA probe (pG4-20) generated by subcloning a 364-bp fragment containing rat NT/ N sequences between -43 and +56 and the first 253 nucleotides of the CAT gene into EcoRI/BamHI sites of a pGEM4 vector, and the antisense fragment was transcribed with SP6 RNA polymerase after linearizing with BamHI. To ensure intact RNA samples and assess any loading differences, separate RNase protection assays were performed using the human GAPDH probe hybridized with duplicate RNA samples.
RNase protection experiments were carried out using the RPA-fl kit according to the instructions of the supplier. Briefly, RNA (5 jg) was hybridized with the 32P-labeled antisense RNA probes overnight at 55°C, followed by RNase digestion for 30 min at room temperature. RNA pellets were dried briefly, resuspended in 8 l of a formamide-loading buffer and RNase-resistant fragments separated on a 5% polyacrylamide-8 M urea gel and visualized by autoradiography.
Isolation of nuclei and run-on assay. To determine whether ras alters the transcription rate of NT/N in CaCo2 cells, nuclear run-on assays were performed (46) . Approximately 3 X 107 CaCo2-ras and CaCo2 cells were washed with phosphate-buffered saline (PBS) and scraped into ice-cold hypotonic lysis buffer (20 mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2) to which 0.5% Nonidet P-40 was later added. Cells were broken with 20-30 strokes in a Dounce homogenizer (B pestle). After centrifugation, nuclear pellets were resuspended in cold nuclear storage buffer (50 mM Tris-HCl [pH 7.5], 0.1 mM EDTA, 5 mM MgCl2, and 40% glycerol) and immediately frozen.
In vitro run-on transcription was carried out using -107 nuclei at 65°C for 1 h. Filters were next incubated with 8 ml RNase-A (10 ILg/ ml) in 2x SSC for 30 min at 37°C and then for 1 h in 2x SSC, and then dried and exposed to x-ray film. Transient transfection, chloramphenicol acetyltransferase (CAT) and /3-galactosidase assays. Rat NT/N 5'-deletion and linker scanning (-189/-182 and -52/-43) reporter constructs have been described previously (49) and provided by Dr. Paul Dobner (University of Massachusetts, Worcester, MA). The expression plasmids, pZIP-Ras(WT) and pZIP-Ras(61L), which encode wild-type (normal) and an activated form (leu 61) of human Ha-ras, respectively, were provided by Dr. Channing J. Der (University of North Carolina, Chapel Hill, NC) (50, 51). Constructs encoding a dominant-negative form of the c-Raf-l protein (Raf-C4) and a mutant of Raf-C4 (Raf-C4pml7), which is no longer dominant-negative, were provided by Dr. Ulf Rapp (National Cancer Institute, Frederick, MD) (52) . All plasmids were prepared by alkaline lysis followed by two successive bandings on cesium chloride density gradients using standard methods (53 protein samples were resolved by sodium dodecyl sulfate (SDS)-12% PAGE and electroblotted onto Immobilon P membranes. Filters were incubated overnight at room temperature in blocking solution (Trisbuffered saline containing 5% nonfat dried milk and 0.05% Tween 20), followed by a 4-h incubation with the rat anti-Ras monoclonal antibody (1:300 dilution). Filters were washed three times and incubated with a horseradish peroxidase-conjugated goat anti-rat immunoglobulin as a secondary antibody (1:1,000 dilution) for 1 h. After three final washes, the immune complexes were visualized using enhanced chemiluminescence detection. into a small bowel-like phenotype (24) . We first determined by a sensitive RNase protection analysis whether the CaCo2-ras cell line expressed the gene for human NT/N, a small bowelassociated endocrine product (Fig. 1 A) . As a positive control, RNA from the human endocrine cell line BON, which is known to constitutively express the NT/N gene (44) , was used and, as expected, demonstrated a 180-base protection product consistent with exon 1 of the human NT/N gene. In addition, NT/N expression was identified in CaCo2-ras (lanes I and 2; Fig. 1  A) . In contrast, the RNA samples from subconfluent cultures of parental CaCo2 cells demonstrated only minimal expression of NT/N (lanes 3 and 4; Fig. 1 A) .
To confirm that NT/N transcripts of the correct size were expressed, Northern blot hybridization was performed (Fig. 1  B) . Consistent with previous reports of NT/N expression in the NT/N gene transcription is increased in CaCo2-ras cells. Nuclear run-on assays were next performed using nuclei isolated from CaCo2-ras and CaCo2 cells to determine whether the dramatic increases in NT/N mRNA were due to alterations in the rate of transcription (Fig. 2) . Cyclophilin and /3-actin were used as positive controls to verify equivalent RNA inputs, and in addition, the pGEM4 plasmid was used to ensure that the signals did not reflect nonspecific hybridization to probe sequences. We found that the apparent rate of transcription of human NT/N was 10-fold higher in CaCo2-ras than in CaCo2 cells when quantitated by densitometry and normalized to the cyclophilin signal for each preparation. The results of these experiments clearly demonstrate an increase in the relative rate of NT/N gene transcription in the Ras-transformed CaCo2 cell line compared with parental CaCo2 cells, suggesting that induction of the NT/N gene is mediated primarily at the transcriptional level. Furthermore, this induction appears specific since neither ,L-actin nor cyclophilin gene transcription was increased in the CaCo2-ras cell line.
A proximal AP-1ICRE promoter element is crucial for Rasmediated NT/N activation. Ras-mediated activation of NT/N may occur as a result of activation of certain transcription factors (e.g., the AP-1 protein c-Jun), which then bind to specific promoter elements of the target gene (10) (11) (12) (13) (14) (15) . Contained within the upstream 200 nucleotides of the NT/N promoter are several important DNA regulatory regions known to be important for induction of NT/N expression in PC12 cells (49) . These include a distal consensus AP-1 site (TGAGTCA) and a proximal nearconsensus AP-1/CRE site (TGACATCA), which is identical to a c-jun autoregulatory element (58) . To define the cis-elements of the NT/N promoter that are responsible for Ras-mediated activation, transient transfection assays were performed using NT/N 5'-deletion constructs linked to the CAT reporter gene (Fig. 3 A) . Deletion of nucleotides between -6000 and -216 produced no decrease in CAT activity; however, deletion from -216 to -43, a minimal promoter plasmid in which the proximal AP-1/CRE element located at -48 to -41 is truncated but still retains the NT/N TATA box, silenced the NT/N promoter when transiently transfected into CaCo2-ras cells.
To better delineate the sequences within these 216 nucleotides that are required for ras activation, linker scanning mutations of the distal consensus AP-1 site, located at -188 to -182, and the proximal AP-1/CRE site were transfected into CaCo2-ras cells (Fig. 3 B) . Mutation of the distal AP-1 site produced only a 25% decrease in CAT activity; however, alteration of the proximal AP-1/CRE promoter element decreased CAT activity > 80%. Taken together, these findings demonstrate that the upstream 216 base pairs of the NT/N promoter are required for Ras-mediated activation and that a proximal AP-1/CRE promoter element appears crucial for this activation.
Oncogenic Ha-ras stimulates NT/N promoter activation in transient cotransfection assays. Expression of NT/N in the stably transfected CaCo2-ras cell line suggested that ras can stimulate the activity of NT/N; however, it is possible that the stimulating effect on the NT/N enhancer in these cells may be secondary to genetic changes as a result of the differentiation process. To test directly whether Ha-ras can stimulate NT/N activity, we used an expression construct (61L) (50, 51) that contains the strongly transforming Ha-ras variant cotransfected with the wild-type (-216/+56) NT/N-CAT vector. Increasing amounts of 61L resulted in dose-dependent increases in NT/N promoter activation (Fig. 4 A) . To further confirm the importance of the proximal NT/N promoter sequences, NT/N deletion constructs of -216, -120, and -43 were cotransfected with ras expression vector 61L (Fig. 4 B) . A 17-fold increase in NT/N promoter activity was noted using the -216 NT/N promoter construct. Deletion to -120, which removes the distal AP-1 site, reduced NT/N activation by only 25%. On the other hand, cotransfection of activated Ras with the truncated -43 NT/N-CAT plasmid produced only a minimal (twofold) increase in NT/N promoter activity compared with control plates not transfected with 61L.
To verify that expression of the CAT gene in the fusion plasmids was under the control of the NT/N promoter, so that the CAT-specific mRNAs were initiated at the authentic NT/N CAP site, RNase protection analyses were performed (Fig. 4  C) . CaCo2 cells transfected with the 5'-deletion fusion genes were analyzed using an RNA probe (pG4-20) to detect hybrid rat NT/N-CAT mRNA (schematic diagram of probe shown at top of Fig. 4 C) . The size of the protected fragments (-312 bases) confirmed that transcription begins at the bona fide rat NT/N transcriptional start site and, in addition, that the changes in CAT activity resulting from progressive deletion of the NT/ N promoter closely parallel changes in mRNA levels. Furthermore, intact RNA samples were confirmed by hybridization with GAPDH and analysis by RNase protection. Collectively, these results, obtained by transient transfection assays, further support the findings of Ras-mediated activation of NT/N and the importance of the proximal NT/N promoter for this activation.
NTIN promoter activity is increased by overexpression of normal c-Ha-ras, and this induction is blocked by a dominantnegative Raf. Thus far, we have shown that activated Ras, either stably or transiently transfected into CaCo2 cells, stimulates NT/N expression. This does not establish, however, whether normal (wild-type) Ras increases NT/N gene expression. To directly assess this possibility, transfection studies using increasing amounts of a plasmid encoding WT-Ras and a constant amount of NT/N-CAT (-216/+56) were performed in CaCo2 cells. Cotransfection of WT-Ras resulted in a dose-dependent increase of NT/N promoter activity with a 4.5-fold increase noted using 10 jug of wild-type (W7T)-Ras (Fig. 5 A) . These increases were relatively modest compared with the 17-fold increase in promoter activity associated with overexpression of oncogenic Ras; however, they provide further support of a role for Ras in the downstream activation of the NT/N gene in the differentiated small bowel.
Next, to ascertain whether Raf kinase lies downstream of Ras, cotransfection studies were performed with Raf constructs that encode a dominant-negative Raf (Raf-C4) and, as a control, a mutant of this dominant-negative Raf that is no longer inhibitory (Raf-C4pml7) (Fig. 5 B) . Dominant-negative Raf blocked the induction of the NT/N promoter by WT-Ras in a dosedependent manner, whereas the inactive version of the dominant-negative Raf had no significant effect on the Ras-mediated stimulation of the NT/N promoter. Taken together, these findings indicate that normal Ras can also stimulate NT/N promoter activity, albeit at lower levels than oncogenic Ras. Furthermore, inhibition of this NT/N promoter activation was observed using a dominant-negative Raf, suggesting that Raf lies downstream of Ras in the signaling pathway that culminates eventually in NT/N gene induction. (Fig. 6 A) . Parallel dishes of CaCo2 cells were extracted for protein and analyzed by Western blot for expression of p21r' using an anti-Ras antibody that detects antigenic determinants common to all three members of the ras gene family.
Similar to NT/N gene expression, increases of p2iras were noted by 6 d postconfluency (Fig. 6 B) ated products (e.g., gut hormones) remain poorly defined. The ras gene family has been implicated in the malignant transformation of a variety of cell types including colonic mucosa (1, 3, 16) ; however, recent studies also suggest an important role for cellular Ras in the differentiation and development of normal tissues. For example, a gradient of p21ral expression is demonstrated in the mucosa of the GI tract with increasing levels noted in the more differentiated cells of the small bowel (25 (59) (60) (61) (62) . These findings indicate that the parental CaCo2 and CaCo2-ras cell lines offer a unique and well-characterized system to further define the cellular mechanisms leading to small bowel differentiation and the regulation of expression of differentiated cellular products of the GI tract, such as the gut hormones, in which little is known about the molecular factors mediating the distinct patterns of cell-specific expression. Expression of the NT/N gene is regulated in a temporaland spatial-specific pattern and is highly dependent on the state of gut differentiation (37, 38) . For example, NT/N expression is limited in the adult GI tract to the small bowel; however, NT/N is expressed in the fetal colon during midgestation when the colon morphologically resembles the small bowel (37) . NT/ N is not expressed in the normal colon of the newborn or the adult. In this study, we have shown that the NT/N gene is expressed in the gut-derived CaCo2 cell line that has been stably transfected with the Ha-ras oncogene. Furthermore, our results clearly indicate that the Ras-mediated induction of NT/N mRNA transcripts is primarily due to an increase in the rate of gene transcription.
Oncogenic ras enhances transcription of certain target genes by activation of various transcription factors (10, 11 (64) .
In addition to the NT/N gene induction noted with activated Ras, we also show that transfection of a plasmid encoding wildtype Ras into CaCo2 cells induces NT/N promoter activity, albeit at lower levels than oncogenic Ras. This induction was inhibited, in a dose-dependent fashion, by a dominant-negative Raf kinase. These findings suggest a role for cellular Ras in the increased expression of the NT/N gene in gut-derived CaCo2 cells. Further evidence to support this speculation is provided by the finding of increased NT/N expression in postconfluent cultures of parental CaCo2 cells that is associated with concomitant increases of p2lr'u protein. Collectively, our results imply a functional requirement for the Ras signaling pathway in the activation of NT/N, a cell-specific endocrine product of the gut.
Consistent with our findings of Ras-mediated increases of NT/N expression, Ras overexpression results in the high-level expression of the peptide hormone calcitonin in a small cell lung cancer cell line (DMS 53) (65) and a medullary thyroid cancer line (MTC) (21) . Furthermore, Conrad et al. (66) recently reported that components of the Ras pathway are required for the regulation of neuroendocrine cell-specific genes in the pituitary gland. Therefore, our findings, as well as those of others (21, 65, 66) , indicate that genes (such as NT/N) expressed in a very strict tissue-specific manner may be subject to Ras regulation.
The results presented in this study indicate that expression of the NT/N gene and NT/N promoter fusion gene constructs is stimulated by p2l'rS expression in human CaCo2 cells that differentiate to a small bowel phenotype. This effect on NT/N is mediated by increases in gene transcription and, in large part, through a palindromic element in the proximal NT/N promoter. Stimulation of NT/N expression is observed both for a stably integrated ras gene and for transiently transfected activated and wild-type ras expression plasmids. These findings are of novel interest in understanding both general mechanisms of promoter responsiveness to Ras and the specific cellular factors regulating differentiated gene expression in the gut. Although previous reports have shown that activated forms of Ras can stimulate neuroendocrine gene expression in various cell lines (21, 65) , ours is one of the first studies documenting that these signaling pathways affect a cellular gene that is normally expressed only in highly differentiated cells of the gut mucosa. Our data also underscore the possibility that tissue-specific genes expressed in highly differentiated and distinct cells of the gut may be subject to Ras regulation and, moreover, Ras may be actively involved in gene regulation during normal gut development and differentiation.
